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Summary
Objectives: In recent years, both the prevalence of obesity and the incidence of RA have been rising. Our aim was to assess the association between overweight or obesity and rheumatoid arthritis (RA).
Design:
Patients who were diagnosed with RA were compared with population-based controls, matched for age and sex (by a ratio of 1:5). Body measurements and smoking status were collected from medical records. Body mass index was classified in WHO categories of underweight, normal, overweight and obese (<18.5, 18.5-<25, 25-<30, ≥30 kg/m 2 ). χ 2 and t-tests and logistic regression models were used to compare the study groups and to assess the association between obesity and RA. Results: The study included 11 406 patients with RA and 54 701 controls. The proportion of obese subjects among RA patients was higher in comparison with controls, (33.4% vs 31.6%, respectively). In multivariate regression model, smoking and obesity were found to be associated with RA, whereas male gender was found as inversely related to RA.
Conclusions: Our findings demonstrate that obesity is significantly associated with RA.
This finding underlines the role that obesity plays in inflammation and autoimmune conditions.
| INTRODUCTION
Obesity remains a major health issue affecting as many as two-thirds of adults in the USA and one-third of American children. 1 Obesity is turning into a substantial public health crisis worldwide; its prevalence is rapidly increasing in numerous industrialised countries. Moreover, the changing patterns of nutrition and activity, as well as the increasing consumption of fast food, have triggered obesity to hit developing countries as well. Overweight and obesity are major risk factors for a number of chronic diseases, including diabetes, cardiovascular diseases and cancer.
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The linkage between obesity and RA is being investigated today from few different aspects. It has been previously shown that obesity raises RA activity and comorbidities alike (cardiovascular disease, type 2 diabetes, chronic pulmonary disease), while decreases the quality of life of RA patients as well as the remission rates of the disease. [6] [7] [8] [9] [10] However, paradoxically, it has been shown that obesity protects from radiographic joint damage. 11 Several studies have examined the po- They also demonstrated that 10 cumulative years of being obese increased the risk of RA at younger ages by 37%.
The underlying hypothesis is that the increased inflammation associated with obesity contributes to the risk and severity of RA. The role of white adipose tissue in modulating immunity and inflammation, in addition of its role as an energy storage under conditions of caloric surplus, demonstrates its importance as an active participant in regulating physiologic and pathologic processes. 13 Adipose tissue produces and secretes a variety of pro-inflammatory and anti-inflammatory factors, including the adipokines leptin, adiponectin, resistin and visfatin as well as cytokines and chemokines, including TNF-a, IL-6, monocyte chemoattractant protein 1 and others.
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The goal of our study was to investigate the linkage between RA and BMI using the large medical database of the Clalit Health Services (CHS), the largest health maintenance organisation (HMO) in Israel.
| METHODS
The study was designed as a cross-sectional analysis utilising the Clalit Health Services (CHS) database. The CHS is the largest man- 
| Statistical analysis

| RESULTS
The study included 11 406 patients with RA and 54 701 age-and sex-matched controls. Characteristics of the study population are presented in Table 1 . The proportion of obesity in patients with RA was increased compared with the controls: 33.4% and 31.6%, respectively, P < .001. There was a significantly higher proportion of smokers among patients with RA as compared to controls (33.5% vs 29.7%, respectively). RA patients had increased odds being in a medium (but not high) SES as compared with controls. In a multivariate logistic regression analysis, obesity was found to be significantly associated with RA (OR 1.09, 95% CI 1.04-1.14). Smoking and obesity were also found to be independently associated with RA whereas male sex was found to be inversely related to RA while (Table 2 ).
| DISCUSSION
Obesity has reached epidemic proportions in many nations. Elevated body mass index, particularly caused by abdominal obesity, has been associated with a number of diseases and metabolic abnormalities, many of which have high morbidity and mortality. 17 Over the last
What was known
• Obesity and inflammation are tightly associated
• Higher circulating inflammatory cytokines have been reported in obese subjects
• Obese patients with rheumatoid arthritis have higher rates of various extra-articular comorbidities
What is new
• The present study has underlined that in a "real life" population insured by the largest health maintenance organisation in Israel, obesity was independently associated with the coexistence of rheumatoid arthritis several decades, there have been several studies addressing the association between RA and obesity and investigating the added risk derived from being obese compared with the general population. [18] [19] [20] The mechanism by which obesity may lead to RA is unidentified. However, there are numerous potential mechanisms to explain this condition; one possible mechanism is based on the association between obesity and chronic inflammation. The obese state is characterised by lowgrade systemic inflammation, as indicated by increased levels of CRP and other inflammatory markers in the circulation of obese and overweight subjects. [21] [22] [23] Far beyond a mere inert lipid storage, the current view of adipose tissue is that of an active secretory organ, producing numerous bioactive molecules that regulate carbohydrate and lipid metabolism, immune function and blood coagulability, modulate appetite and may serve as blood markers of cardio metabolic risk. These mediators play a major role in the human body physiology and can have an effect on insulin resistance, metabolic syndrome and cardiovascular disease. 24, 25 Given that ongoing inflammation marks many autoimmune diseases, chronic obesity presents a predisposed systemic environment to support the progression of autoimmune diseases. Altered systemic adipokines levels and/or local adipokines levels have been reported in a variety of autoimmune conditions. 26, 27 Increased expression of leptin has been associated with multiple autoimmune diseases. 27 Moreover, leptin has emerged as an important regulator of inflammation, by acting as a pro-inflammatory mediator during both the innate and the adaptive immune response.
28
Several studies have shown that leptin-deficient mice have a reduced inflammatory reponse when rheumatoid-like disease was induced. 29, 30 Previous studies have also shown that adiponectin and resistin levels are elevated in the synovial fluids of patients with RA compared with that seen in patients with osteoarthritis and found a positive correlation between resistin and systemic markers of inflammation such as CRP.
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Another possible mechanism for the association between obesity and RA may derive from the prevalent occurrence of vitamin D deficiency among obese individuals. Vitamin D deficiency is known to be highly prevalent among individuals with different autoimmune disorders including RA.
32,33
An additional mechanism is based on the relationship between obesity and sex hormones. Obese men and women have higher serum levels of estrogens and androgens. Estrogen not only stimulates antibody (and autoantibody) production but also has a role in the breakdown of B-cell tolerance. [34] [35] [36] Our study clearly validates this suggested association between RA and obesity. The results clearly point out that RA occurs more frequently among obese people. Nevertheless, since our study is crosssectional, it is essential to deal with the question whether RA can lead to obesity. No data was found dealing with this question. Despite that, there are few mechanisms leading to weight gain in RA. Firstly, the joint pain can lead to immobility and consequent weight gain.
Secondly, corticosteroids, a common treatment for RA, often ends up with weight gain. In this article, we focused on the role obesity may have as a risk factor for coexistent RA. The strength of this research arises mainly from the large sample size for both study and control groups. Moreover, the extensive demographic information from the CHS database, which included the entire population of the Clalit Medical Database, allowed for this comprehensive analysis. However, our study has several limitations. The study has an observational design and not an interventional one, which is an inherent limitation to any cross-sectional study of this type. Previous experience with the CHS population-based study has indicated that the data are of high quality and that the associations that were detected were identical to those that were observed when smaller groups of patients with definite diagnoses were used. [37] [38] [39] [40] [41] Our study revealed statistically significant difference towards medium (but not high) SES among RA patients as compared with controls, but the difference was small and without an overt clinical impact.
In conclusion, this research underlines the significance of obesity as an independent factor associated with RA. A better understanding of the arthritis-obesity interaction will help us to improve a personalised management directed against both the disease and its associated comorbidities. 
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